Ephrin-B2 promotes nociceptive plasticity and hyperalgesic priming through EphB2-MNK-eIF4E signaling in both mice and humans
暂无分享,去创建一个
M. Dalva | G. Dussor | Kolluru D. Srikanth | Eric T. David | Sharada Krishnagiri | Theodore J. Price | Muhammad Saad Yousuf | Hao-Ruei Mei | Ashita Jain
[1] M. Dalva,et al. VLK drives extracellular phosphorylation of EphB2 to govern the EphB2-NMDAR interaction and injury-induced pain , 2024, bioRxiv.
[2] J. Lennerz,et al. Harmonized cross-species cell atlases of trigeminal and dorsal root ganglia , 2023, bioRxiv.
[3] Megan L Uhelski,et al. MNK inhibitor eFT508 (Tomivosertib) suppresses ectopic activity in human dorsal root ganglion neurons from dermatomes with radicular neuropathic pain , 2023, bioRxiv.
[4] S. Hassler,et al. PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine model , 2023, The Journal of Headache and Pain.
[5] E. Walters,et al. Persistent nociceptor hyperactivity as a painful evolutionary adaptation , 2023, Trends in Neurosciences.
[6] G. Dussor,et al. MNK1/2 contributes to periorbital hypersensitivity and hyperalgesic priming in preclinical migraine models. , 2022, Brain : a journal of neurology.
[7] M. Parisien,et al. Long-term male-specific chronic pain via telomere- and p53‑mediated spinal cord cellular senescence , 2022, The Journal of clinical investigation.
[8] J. Lennerz,et al. Human and mouse trigeminal ganglia cell atlas implicates multiple cell types in migraine , 2022, Neuron.
[9] P. Dougherty,et al. Spatial transcriptomics of dorsal root ganglia identifies molecular signatures of human nociceptors , 2022, Science Translational Medicine.
[10] M. Togha,et al. Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2 , 2022, The Journal of Headache and Pain.
[11] S. Waxman,et al. Human cells and networks of pain: Transforming pain target identification and therapeutic development , 2021, Neuron.
[12] R. Lipton,et al. Migraine: epidemiology and systems of care , 2021, The Lancet.
[13] S. Belugin,et al. Meningeal CGRP‐Prolactin Interaction Evokes Female‐Specific Migraine Behavior , 2021, Annals of neurology.
[14] P. Ray,et al. A ligand-receptor interactome platform for discovery of pain mechanisms and therapeutic targets , 2021, Science Signaling.
[15] R. Bachoo,et al. Identification of tetracycline combinations as EphB1 tyrosine kinase inhibitors for treatment of neuropathic pain , 2021, Proceedings of the National Academy of Sciences.
[16] Stephanie I. Shiers,et al. Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain , 2020, Pharmacological Reviews.
[17] G. Dussor,et al. De novo protein synthesis is necessary for priming in preclinical models of migraine , 2020, Cephalalgia : an international journal of headache.
[18] Stephanie I. Shiers,et al. Convergence of peptidergic and non-peptidergic protein markers in the human dorsal root ganglion and spinal dorsal horn , 2020, bioRxiv.
[19] G. Dussor,et al. IL-6 induced upregulation of T-type Ca2+ currents and sensitization of DRG nociceptors is attenuated by MNK inhibition. , 2020, Journal of neurophysiology.
[20] J. Mogil. Qualitative sex differences in pain processing: emerging evidence of a biased literature , 2020, Nature Reviews Neuroscience.
[21] A. El-Khoueiry,et al. A phase II, open-label study of tomivosertib (eFT508) added on to continued checkpoint inhibitor therapy in patients (pts) with insufficient response to single-agent treatment. , 2020 .
[22] G. Boeckxstaens,et al. Ephrin‐B2 signaling in the spinal cord as a player in post‐inflammatory and stress‐induced visceral hypersensitivity , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[23] M. Dalva,et al. Positive surface charge of GluN1 N-terminus mediates the direct interaction with EphB2 and NMDAR mobility , 2020, Nature Communications.
[24] Lixue Chen,et al. EphrinB/EphB Signaling Contributes to the Synaptic Plasticity of Chronic Migraine Through NR2B Phosphorylation , 2020, Neuroscience.
[25] J. Pancrazio,et al. Reversal of peripheral nerve injury-induced neuropathic pain and cognitive dysfunction via genetic and tomivosertib targeting of MNK , 2019, Neuropsychopharmacology.
[26] G. Dussor. New discoveries in migraine mechanisms and therapeutic targets. , 2019, Current opinion in physiology.
[27] P. Ray,et al. Recent advances toward understanding the mysteries of the acute to chronic pain transition. , 2019, Current opinion in physiology.
[28] E. Walters,et al. MNK-eIF4E signalling is a highly conserved mechanism for sensory neuron axonal plasticity: evidence from Aplysia californica , 2019, Philosophical Transactions of the Royal Society B.
[29] P. Ray,et al. Differences between Dorsal Root and Trigeminal Ganglion Nociceptors in Mice Revealed by Translational Profiling , 2019, The Journal of Neuroscience.
[30] G. Rätsch,et al. HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness , 2019, Science Translational Medicine.
[31] G. Rao,et al. Electrophysiological and transcriptomic correlates of neuropathic pain in human dorsal root ganglion neurons. , 2019, Brain : a journal of neurology.
[32] M. Burton,et al. Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models , 2019, The Journal of Neuroscience.
[33] A. Jimeno,et al. Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers. , 2019, Cancer research.
[34] N. Sonenberg,et al. Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic Pain , 2018, The Journal of Neuroscience.
[35] M. Dalva,et al. EphBs and ephrin-Bs: Trans-synaptic organizers of synapse development and function , 2018, Molecular and Cellular Neuroscience.
[36] G. Dussor,et al. Non-invasive dural stimulation in mice: A novel preclinical model of migraine , 2018, Cephalalgia : an international journal of headache.
[37] Lars E. Borm,et al. Molecular Architecture of the Mouse Nervous System , 2018, Cell.
[38] J. Moy,et al. eIF4E phosphorylation regulates ongoing pain, independently of inflammation, and hyperalgesic priming in the mouse CFA model , 2018, Neurobiology of pain.
[39] P. A. Thompson,et al. Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition. , 2018, Journal of medicinal chemistry.
[40] Rebecca P Seal,et al. A Critical Role for Dopamine D5 Receptors in Pain Chronicity in Male Mice , 2018, The Journal of Neuroscience.
[41] Christos G. Gkogkas,et al. The MNK–eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic Pain , 2017, The Journal of Neuroscience.
[42] Daniel S Spellman,et al. Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain , 2017, PLoS biology.
[43] J. Mogil,et al. Sex differences in neuroimmunity and pain , 2017, Journal of neuroscience research.
[44] C. Burgos-Vega,et al. Dural stimulation in rats causes brain-derived neurotrophic factor–dependent priming to subthreshold stimuli including a migraine trigger , 2016, Pain.
[45] J. Mogil. Perspective: Equality need not be painful , 2016, Nature.
[46] F. Gage,et al. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro , 2015, Proceedings of the National Academy of Sciences.
[47] J. Levine,et al. The fundamental unit of pain is the cell , 2013, PAIN®.
[48] C. Becker,et al. Comprehensive RNA-Seq Expression Analysis of Sensory Ganglia with a Focus on Ion Channels and GPCRs in Trigeminal Ganglia , 2013, PloS one.
[49] T. Sears,et al. Involvement of EphB1 Receptors Signalling in Models of Inflammatory and Neuropathic Pain , 2013, PloS one.
[50] J. Olesen,et al. Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura , 2012, The Journal of Headache and Pain.
[51] N. Sonenberg,et al. Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4E , 2012, Nature Immunology.
[52] M. Henkemeyer,et al. Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents. , 2011, Cancer research.
[53] M. Asiedu,et al. Spinal Protein Kinase M ζ Underlies the Maintenance Mechanism of Persistent Nociceptive Sensitization , 2011, The Journal of Neuroscience.
[54] M. Dalva,et al. EphB Controls NMDA Receptor Function and Synaptic Targeting in a Subunit-Specific Manner , 2011, The Journal of Neuroscience.
[55] P. Goadsby,et al. Acute Migraine Therapy: New Drugs and New Approaches , 2010, Current treatment options in neurology.
[56] K. Kullander,et al. Nociceptor-expressed ephrin-B2 regulates inflammatory and neuropathic pain , 2010, Molecular pain.
[57] J. Levine,et al. Critical role of nociceptor plasticity in chronic pain , 2009, Trends in Neurosciences.
[58] M. Henkemeyer,et al. An in vivo mouse model of long-term potentiation at synapses between primary afferent C-fibers and spinal dorsal horn neurons: essential role of EphB1 receptor , 2009, Molecular pain.
[59] David G. Wilkinson,et al. Regulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway , 2008, The Journal of cell biology.
[60] Wen-tao Liu,et al. EphrinB-EphB receptor signaling contributes to neuropathic pain by regulating neural excitability and spinal synaptic plasticity in rats , 2008, PAIN.
[61] V. Cibert-Goton,et al. EphrinB2 induces tyrosine phosphorylation of NR2B via Src-family kinases during inflammatory hyperalgesia , 2008, Neuroscience.
[62] Xinzhong Dong,et al. Pirt, a Phosphoinositide-Binding Protein, Functions as a Regulatory Subunit of TRPV1 , 2008, Cell.
[63] M. Henkemeyer,et al. Targeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in mice , 2008, Molecular pain.
[64] M. Homma,et al. Involvement of EphB1 Receptor/EphrinB2 Ligand in Neuropathic Pain , 2007, Spine.
[65] R. Quirion,et al. The ERK/MAPK pathway, as a target for the treatment of neuropathic pain , 2005, Expert opinion on therapeutic targets.
[66] R. Traub,et al. Cutaneous and colonic rat DRG neurons differ with respect to both baseline and PGE2-induced changes in passive and active electrophysiological properties. , 2004, Journal of neurophysiology.
[67] S. McMahon,et al. EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processing , 2003, Nature Neuroscience.
[68] Yi Dai,et al. Phosphorylation of Extracellular Signal-Regulated Kinase in Primary Afferent Neurons by Noxious Stimuli and Its Involvement in Peripheral Sensitization , 2002, The Journal of Neuroscience.
[69] Michael E Greenberg,et al. EphB Receptors Interact with NMDA Receptors and Regulate Excitatory Synapse Formation , 2000, Cell.
[70] K. Fried,et al. Sympathetic nerve sprouting fails to occur in the trigeminal ganglion after peripheral nerve injury in the rat , 1999, PAIN.
[71] T. Yaksh,et al. Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.
[72] R. Dubner,et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.
[73] Theodore John Price,et al. Commonalities between pain and memory mechanisms and their meaning for understanding chronic pain. , 2015, Progress in molecular biology and translational science.
[74] G. Tosato,et al. Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. , 2012, Advances in cancer research.